"
Team:Hong Kong HKU/humanpractice/safety
From 2013.igem.org
| Line 17: | Line 17: | ||
</font> | </font> | ||
<br><br> | <br><br> | ||
| - | <font face=" | + | <font face="arial" size="2"> |
Answer for Q1. | Answer for Q1. | ||
</font> | </font> | ||
<br><br> | <br><br> | ||
| - | <font face=" | + | <font face="arial" size="5"> |
Q2. Highest Risk Group Listed: | Q2. Highest Risk Group Listed: | ||
</font><br><br> | </font><br><br> | ||
| - | <font face=" | + | <font face="arial" size="2"> |
1: Greater than 1 | 1: Greater than 1 | ||
</font><br><br> | </font><br><br> | ||
| - | <font face=" | + | <font face="arial" size="5"> |
Q3. List and describe all new or modified coding regions you will be using in your project. (If you use parts from the 2013 iGEM Distribution without modifying them, you do not need to list those parts.) | Q3. List and describe all new or modified coding regions you will be using in your project. (If you use parts from the 2013 iGEM Distribution without modifying them, you do not need to list those parts.) | ||
</font> | </font> | ||
<br><br> | <br><br> | ||
| - | <font face=" | + | <font face="arial" size="5"> |
Q4. Do the biological materials used in your lab work pose any of the following risks? Please describe. a. | Q4. Do the biological materials used in your lab work pose any of the following risks? Please describe. a. | ||
Risks to the safety and health of team members or others working in the lab? | Risks to the safety and health of team members or others working in the lab? | ||
| Line 37: | Line 37: | ||
</font> | </font> | ||
<br><br> | <br><br> | ||
| - | <font face=" | + | <font face="arial" size="2"> |
The E. coli strain DH10B and BL21 was used throughout our project. Both are Risk Group 1 laboratory strains of E. coli that have a low, but not nonexistent, virulence. Organisms classified as Risk Group 1 are not known to cause disease in healthy adults. Keeping with registration requirements for Risk Group 1 bacteria, all laboratory work was performed in an environment certified for Biosafety Level 1. Hence, they pose low risk to the safety and health of team members or others working in the lab. | The E. coli strain DH10B and BL21 was used throughout our project. Both are Risk Group 1 laboratory strains of E. coli that have a low, but not nonexistent, virulence. Organisms classified as Risk Group 1 are not known to cause disease in healthy adults. Keeping with registration requirements for Risk Group 1 bacteria, all laboratory work was performed in an environment certified for Biosafety Level 1. Hence, they pose low risk to the safety and health of team members or others working in the lab. | ||
</font> | </font> | ||
<br><br> | <br><br> | ||
| - | <font face=" | + | <font face="arial" size="5"> |
Q4. b. Risks to the safety and health of the general public, if released by design or by accident? | Q4. b. Risks to the safety and health of the general public, if released by design or by accident? | ||
</font> | </font> | ||
<br><br> | <br><br> | ||
| - | <font face=" | + | <font face="arial" size="2"> |
These strains of E. coli are generally not resistant to antibiotics. All bacteria were transformed with bacterial plasmids carrying our desired insert gene and antibiotics resistance to antibiotics commonly used in laboratories for selection (ampicillin, kanamycin, chloramphenicol, etc.), but will not interfere with potential clinical treatment. Neither plasmids nor their insert genes will affect virulence, infectivity, or host range. | These strains of E. coli are generally not resistant to antibiotics. All bacteria were transformed with bacterial plasmids carrying our desired insert gene and antibiotics resistance to antibiotics commonly used in laboratories for selection (ampicillin, kanamycin, chloramphenicol, etc.), but will not interfere with potential clinical treatment. Neither plasmids nor their insert genes will affect virulence, infectivity, or host range. | ||
| Line 54: | Line 54: | ||
<br><br> | <br><br> | ||
| - | <font face=" | + | <font face="arial" size="5"> |
c. Risks to the environment, if released by design or by accident? | c. Risks to the environment, if released by design or by accident? | ||
| Line 60: | Line 60: | ||
<br> | <br> | ||
<br> | <br> | ||
| - | <font face=" | + | <font face="arial" size="2"> |
We have no intention of releasing any bacteria into the human body or the environment at any point in the iGEM competition. Even if it did "escape' from our lab, the bacteria is effectively harmless; as stated above, neither our plasmids nor our insert genes will affect the virulence, infectivity, or host range. | We have no intention of releasing any bacteria into the human body or the environment at any point in the iGEM competition. Even if it did "escape' from our lab, the bacteria is effectively harmless; as stated above, neither our plasmids nor our insert genes will affect the virulence, infectivity, or host range. | ||
</font> | </font> | ||
<br> | <br> | ||
<br> | <br> | ||
| - | <font face=" | + | <font face="arial" size="5"> |
d. Risks to security through malicious misuse by individuals, groups, or countries? | d. Risks to security through malicious misuse by individuals, groups, or countries? | ||
| Line 71: | Line 71: | ||
<br> | <br> | ||
<br> | <br> | ||
| - | <font face=" | + | <font face="arial" size="2"> |
The bacteria is effectively harmless, neither our plasmids nor our insert genes will affect the virulence, infectivity, or the host range. | The bacteria is effectively harmless, neither our plasmids nor our insert genes will affect the virulence, infectivity, or the host range. | ||
</font> | </font> | ||
Revision as of 06:22, 25 September 2013
Q1. Please describe the chassis organism(s) you will be using for this project. If you will be using more than one chassis organism, provide information on each of them:
Answer for Q1.
Q2. Highest Risk Group Listed:
1: Greater than 1
Q3. List and describe all new or modified coding regions you will be using in your project. (If you use parts from the 2013 iGEM Distribution without modifying them, you do not need to list those parts.)
Q4. Do the biological materials used in your lab work pose any of the following risks? Please describe. a.
Risks to the safety and health of team members or others working in the lab?
The E. coli strain DH10B and BL21 was used throughout our project. Both are Risk Group 1 laboratory strains of E. coli that have a low, but not nonexistent, virulence. Organisms classified as Risk Group 1 are not known to cause disease in healthy adults. Keeping with registration requirements for Risk Group 1 bacteria, all laboratory work was performed in an environment certified for Biosafety Level 1. Hence, they pose low risk to the safety and health of team members or others working in the lab.
Q4. b. Risks to the safety and health of the general public, if released by design or by accident?
These strains of E. coli are generally not resistant to antibiotics. All bacteria were transformed with bacterial plasmids carrying our desired insert gene and antibiotics resistance to antibiotics commonly used in laboratories for selection (ampicillin, kanamycin, chloramphenicol, etc.), but will not interfere with potential clinical treatment. Neither plasmids nor their insert genes will affect virulence, infectivity, or host range.
c. Risks to the environment, if released by design or by accident?
We have no intention of releasing any bacteria into the human body or the environment at any point in the iGEM competition. Even if it did "escape' from our lab, the bacteria is effectively harmless; as stated above, neither our plasmids nor our insert genes will affect the virulence, infectivity, or host range.
d. Risks to security through malicious misuse by individuals, groups, or countries?
The bacteria is effectively harmless, neither our plasmids nor our insert genes will affect the virulence, infectivity, or the host range.
|
|
